In
the blood pressure study, 26 groups of animals (6/group, sex not specified) were fed
Tekland rat chow and administered barium in their drinking water for 16 weeks. Five groups of
CD Sprague-Dawley rats received 0, 3, 10, or 100 ppm barium in their drinking water. The same
concentrations of barium were administered to five groups of CD Sprague-Dawley rats in 0.9%
NaCl. Eight additional groups of unilaterally nephrectomized CD Sprague-Dawley rats received
1, 10, 100, or 1000 ppm barium in either water or 0.9% NaCl. These same concentrations of
barium were provided in 0.9% NaCl to two specially bred strains of rats: Dahl salt-sensitive and
Dahl salt-resistant. These inbred strains are derived from Sprague-Dawley rats and used to study
salt-dependent hypertension. Estimated doses corresponding to 0, 1, 3, 10, 30, 100, and 1000
ppm exposures were 0, 0.15, 0.45, 1.5, 4.5, 15, and 150 mg/kg-day, respectively.
The salt-sensitive Dahl rats had transiently elevated blood pressure (approximately 150
160 mm Hg) during the first 1-2 weeks of exposure to 1 or 10 ppm barium. The investigators
considered this to be an effect of the NaCl solution on the salt-sensitive animals. No evidence of
hypertension was observed in Dahl salt-resistant rats that received the same treatments. Some
fluctuations of blood pressure were observed in other treatment groups, but none were
considered to be indicative of hypertension. Thus, there was no indication that barium
contributed to hypertension in this animal model, but further interpretation of the results is
problematic because of the lack of control groups.
Electron microscopy examination of the kidneys was conducted for all rats in the blood
pressure studies. Structural changes were observed in the glomeruli of rats that received 1000
ppm BaCl
2
×2H
2
O, including fused podocyte processes, thickening of the capillary basement
membrane, and myelin figures in Bowman’s space. No histopathologic changes were observed
in the arteriolar vessel walls or in the tubules of the nephrons.
The only groups that received 1000 ppm barium were the unilaterally nephrectomized
rats and the Dahl salt-sensitive and salt-resistant rats that received barium in 0.9% NaCl.
Normal CD Sprague-Dawley rats were not tested at this exposure level. No glomerular effects
were seen at the next lower exposure level, 100 ppm, or in any other treatment group.
4.2.1.6. Tardiff et al. (1980)
Tardiff et al. (1980) exposed male and female Charles River rats (30 animals/dose /sex)
continuously to 0, 10, 50, or 250 ppm barium (as barium chloride) in drinking water for 4, 8, or
13 weeks. The authors estimated doses for the treated groups as 1.7, 8.1, and 38.1 mg Ba/kg-day
24
for males and 2.1, 9.7, and 45.7 mg Ba/kg-day for females. Rats were fed Tekland mouse/rat
diet pellets, which contributed a baseline dose of 0.5
:
g Ba/kg-day. No deaths occurred and
there were no clinical signs of toxicity. Food consumption and body weights in the treated
groups were essentially the same as in the control groups. Water consumption, however, was
depressed in both sexes at 250 ppm barium. Slight decreases in relative adrenal weights
occurred in males at
$
50 ppm at 8 weeks and in females at all barium concentrations at 13
weeks, but these changes were not dose related, and a slight increase occurred in females at 250
ppm at 8 weeks. No treatment-related changes were seen in hematologic parameters, serum
alkaline phosphatase, serum glutamate oxalate transaminase, serum glutamate pyruvate
transaminase, BUN, serum ions (sodium, potassium, calcium), gross pathology, and
histopathology of the liver, kidneys, spleen, heart, brain, muscle, femur, and adrenal glands.
Blood pressure and endpoints sensitive for glomerular damage (electron microscopic
examination or urinary excretion of protein) were not investigated. This study identifies a
subchronic NOAEL of 250 ppm (38.1-45.7 mg Ba/kg-day).
4.2.1.7. Perry et al. (1989, 1985)
Perry et al. (1989, 1985) exposed female weanling Long-Evans rats to 0, 1, 10, or 100
ppm barium (as barium chloride) in drinking water for 1, 4, and 16 months (13 treated rats per
duration and 21 control rats per duration). Drinking water was fortified with five essential
metals (1 ppm molybdenum, 1 ppm cobalt, 5 ppm copper, 10 ppm manganese, and 50 ppm zinc).
All animals received a rye-based diet with low trace metal content. The diet contained 1.5 ppm
barium and 3,800 ppm calcium. Based on a time-weighted average (TWA) water intake (20
mL/day) and body weight (0.334 kg) estimated from reported values for the 16-month period,
barium doses from drinking water can be estimated at 0, 0.06, 0.6, and 6 mg Ba/kg-day. The diet
contained 1.5 ppm barium. Based on the TWA body weight and a TWA food intake of 20 g/day
estimated from reported values for the 16-month period, the barium dose from the diet can be
estimated at 0.1 mg Ba/kg-day. Combining the doses from water and diet results in estimated
intakes of 0.1, 0.15, 0.7, and 6 mg Ba/kg-day. The cumulative intake from drinking water and
diet was reported by the authors as 16, 28, 134, and 1198 mg Ba/rat for the 0, 1, 10, and 100 ppm
groups at 16 month (termination). Dividing the total doses by the TWA body weight and by 487
days (16 month) gives estimated doses from water plus diet of 0.1, 0.2, 0.8, and 7 mg Ba/kg-day.
These values are similar to those estimated above from the water and diet concentrations of
barium. All the above estimates are approximate because the authors reported intake and body
weight values only for controls, stating that the values for the dosed groups were no different.
Accordingly, the TWA body weight and water and food intake values above were based on the
control data and were used for all exposure groups.
25